Jeffrey A Meckler is CEO and Director of Indaptus Therapeutics, Inc.. Currently has a direct ownership of 160,306 shares of INDP, which is worth approximately $190,764. The most recent transaction as insider was on Aug 08, 2024, when has been sold 84,932 shares (Common Stock) at a price of $1.82 per share, resulting in proceeds of $154,576. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 160K
0% 3M change
112.68% 12M change
Total Value Held $190,764

Jeffrey A Meckler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 08 2024
BUY
Grant, award, or other acquisition
$154,576 $1.82 p/Share
84,932 Added 34.63%
160,306 Common Stock
Nov 21 2022
BUY
Open market or private purchase
$18,240 $1.9 p/Share
9,600 Added 11.3%
75,374 Common Stock
Nov 18 2022
BUY
Open market or private purchase
$704 $1.76 p/Share
400 Added 0.6%
65,774 Common Stock
Sep 08 2022
BUY
Open market or private purchase
$28,862 $2.8 p/Share
10,308 Added 13.62%
65,374 Common Stock
Sep 07 2022
BUY
Open market or private purchase
$22,184 $2.57 p/Share
8,632 Added 13.55%
55,066 Common Stock
Sep 06 2022
BUY
Open market or private purchase
$2,586 $2.44 p/Share
1,060 Added 2.23%
46,434 Common Stock
Jun 06 2022
BUY
Open market or private purchase
$51,882 $2.63 p/Share
19,727 Added 30.3%
45,374 Common Stock
Nov 18 2021
BUY
Open market or private purchase
$65,108 $5.82 p/Share
11,187 Added 30.37%
25,647 Common Stock
Sep 14 2021
BUY
Open market or private purchase
$84,000 $7.0 p/Share
12,000 Added 45.35%
14,460 Common Stock

Also insider at

TVTX
Travere Therapeutics, Inc. Healthcare
JAM

Jeffrey A Meckler

CEO and Director
New York, NY

Track Institutional and Insider Activities on INDP

Follow Indaptus Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INDP shares.

Notify only if

Insider Trading

Get notified when an Indaptus Therapeutics, Inc. insider buys or sells INDP shares.

Notify only if

News

Receive news related to Indaptus Therapeutics, Inc.

Track Activities on INDP